We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Interpharm Holdings, Inc. (Amex: IPA) (?Interpharm?), a manufacturer and distributor of generic pharmaceutical products, announced today that it has notified the American Stock...
Interpharm Holdings, Inc. (Amex: IPA)(?Holdings?), a manufacturer and distributor of generic pharmaceutical products, announced today that it received a notice from the American...
Interpharm Holdings, Inc. (Amex: IPA), a manufacturer and distributor of generic pharmaceutical products, reported net sales of $19.91 million and a net loss of ($1.85) million...
Interpharm Holdings, Inc. (Amex: IPA), a manufacturer and distributor of generic pharmaceutical products, reported record sales of $22.83 million and net income of $1.63 million...
Interpharm Holdings, Inc. (Amex: IPA), a manufacturer and distributor of generic pharmaceutical products, today announced its financial results for the fiscal year ended June...
Interpharm Holdings, Inc. (Amex: IPA), a manufacturer and distributor of generic pharmaceuticals, today announced it has closed its $10 million capital financing with Tullis-Dickerson...
Interpharm Holdings, Inc. (Amex: IPA), a manufacturer and distributor of generic pharmaceutical drugs, today announced it has entered into a stock purchase agreement with Tullis-Dickerson Capital...
Interpharm Holdings, Inc. (Amex: IPA), a manufacturer and distributor of generic pharmaceutical drugs, today announced its financial results for the three and nine month periods ended March...
Interpharm Holdings, Inc. (Amex:IPA), a manufacturer and distributor of generic pharmaceutical drugs, today announced its financial results for the fiscal quarter ended December 31, 2005. -0- *T...
NEW YORK, Feb. 13 /PRNewswire-FirstCall/ -- Wells Fargo Business Credit, part of Wells Fargo & Company (NYSE:WFC), has provided a four-year $41.5 million senior secured credit facility to...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions